Curexo, Inc.
USPTO PatentsView assignee record - 30 granted patents across 12 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Curexo ranks #10,300 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 12 technology areas.
- #10,300
- of 49,997 US assignees by volume
- Top 28%
- by Innovation Score (43.3/100)
- 9.7
- avg claims per patent
- +500%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10300 · Foreign Corporation #10,300 · 30 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 30 grants
- UPPER-Q #10,300/49,997
- PHOTO-FINISH Caisson Interventional
- CPC-FOCUS A61B · 12 areas
- INNOV-PAR 43.3/100
- CLAIMS-PAR 9.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +500% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Caisson Interventional LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Curexo’s 43.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Curexo
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Curexo · this assignee
Curexo · this assignee
43 score
- GKN Sinter Metals · near
GKN Sinter Metals · near
43 score
- Purina Animal… · near
Purina Animal… · near
43 score
- Rev-a-shelf · near
Rev-a-shelf · near
43 score
- Veoneer Sweden AB · near
Veoneer Sweden AB · near
43 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Curexo's Innovation Score is 43.3/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Curexo?
Each dot is one of Curexo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Curexo’s own 9.7 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Curexo's grants concentrate
Curexo, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 73.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2016. By volume, Curexo sits between Chips & Media, Inc and Carl Zeiss MultiSEM GmbH.
Curexo's three-year grant acceleration
Curexo, Inc. shows 16 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Curexo's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Chips & Media
Chips & Media, Inc
30 patents
- Coorstek KK
Coorstek KK
30 patents
- Crititech
Crititech, Inc.
30 patents
- CUB Elecparts
CUB Elecparts Inc.
30 patents
- Caisson Intervent…
Caisson Interventional LLC
30 patents
- Camplex
CamPlex, Inc.
30 patents
- Candela
Candela Corporation
30 patents
- Carl Zeiss Multis…
Carl Zeiss MultiSEM GmbH
30 patents
- Curexo ◀
Curexo, Inc.
30 patents
What this shows Curexo holds 30 patents at rank #10,280, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Curexo
By rank, the assignees closest to #10,280 in granted patent volume.
- Chips & Media, Inc #10,276 · 30 patents
- Coorstek KK #10,277 · 30 patents
- Crititech, Inc. #10,278 · 30 patents
- CUB Elecparts Inc. #10,279 · 30 patents
- Caisson Interventional LLC #10,281 · 30 patents
- CamPlex, Inc. #10,282 · 30 patents
- Candela Corporation #10,283 · 30 patents
- Carl Zeiss MultiSEM GmbH #10,284 · 30 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Curexo's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Curexo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Curexo ranks #818 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (43 here).
Curexo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 28% higher than 72% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 3.3% |
| 2017 | 2 | 6.7% |
| 2018 | 1 | 3.3% |
| 2020 | 2 | 6.7% |
| 2021 | 6 | 20.0% |
| 2022 | 6 | 20.0% |
| 2023 | 8 | 26.7% |
| 2024 | 2 | 6.7% |
| 2025partial year | 2 | 6.7% |
Which technologies does Curexo, Inc. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Curexo, Inc.'s patent record in context - here's where to go next.
- Curexo, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 73.3% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #10,300 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Curexo, Inc. against Chips & Media, Inc, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.